Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia

BACKGROUND: The high prevalence of methicillin-resistant S. aureus (MRSA) has led clinicians to select antibiotics that have coverage against MRSA, usually vancomycin, for empiric therapy for suspected staphylococcal infections. Clinicians often continue vancomycin started empirically even when meth...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Schweizer, Marin L, Furuno, Jon P, Harris, Anthony D, Johnson, J Kristie, Shardell, Michelle D, McGregor, Jessina C, Thom, Kerri A, Cosgrove, Sara E, Sakoulas, George, Perencevich, Eli N
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2011
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3206863/
https://ncbi.nlm.nih.gov/pubmed/22011388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-11-279
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires